Cannabix Technol Stock Price, News & Analysis

Cannabix Technologies (OTC:BLOZF) has received a notice of allowance from the Canadian Intellectual Property Office (CIPO) for its patent application titled "Contact-Free Breath Analysis Device and Method." This follows a similar notice from the U.S. Patent and Trademark Office for the same technology.

The patent covers dual-mode contactless breath capture and analysis technology that can be integrated into vehicles, workplaces, and public kiosks. The system features unmanned testing capabilities, real-time feedback, and intelligent airflow adjustment mechanisms, making it particularly valuable for law enforcement, workplace safety, and public health monitoring applications.

Cannabix Technologies (OTC:BLOZF) has initiated its first production run of BreathLogix alcohol screening devices, partnering with Price Electronics as their contract manufacturer. Price Electronics, with their 28,000 square foot facility in Winnipeg, brings significant credentials including ISO 13485, ISO9001, and IPC certifications.

The BreathLogix "Workplace Series" device has received National Highway Traffic Safety Association approval and has been added to the U.S. Federal Register Conforming Products List for breath alcohol screening devices. Additionally, the company has secured an exclusive distribution agreement with Breathalyser Sales & Service Pty Ltd. for Australia, New Zealand, and the Pacific Islands.

Cannabix Technologies (BLOZF) has received a notice of allowance from the USPTO for its patent application on contactless breath analysis technology. The patent, titled 'Contact-Free Breath Analysis Device and Method,' covers innovative dual-mode breath capture and analysis technology that can operate both contactlessly and with traditional mouthpieces. The system can be integrated into vehicles, workplaces, and public kiosks, offering real-time feedback through visual indicators. The technology features intelligent airflow adjustment mechanisms and is designed for applications in law enforcement, workplace safety, and public health monitoring. While the notice of allowance has been issued, it does not yet constitute a final patent grant.

Cannabix Technologies announces a significant milestone as Omega Laboratories delivers a Validation Packet for their Marijuana Breath Test (MBT) technology. The validation, conducted in Omega's ISO/IEC 17025 accredited laboratory, confirms a test method for detecting multiple cannabis compounds including THC in breath samples. This development positions Cannabix and Omega as leaders in recent marijuana usage detection through breath testing, offering advantages over traditional urine, blood, and saliva methods. As part of their strategic partnership agreement, Omega will receive 3 million Special Warrant Shares and rights to appoint a board member. Omega is currently integrating Cannabix's Breath Cartridges into its testing services, with both companies collaborating on marketing, distribution, and logistics for commercial launch.

Cannabix Technologies (BLOZF) has selected Price Industries Ltd. as the contract manufacturer for its BreathLogix alcohol screening device product line. Price Electronics, with its 28,000 square foot facility in Winnipeg, holds ISO 13485, ISO9001, and IPC certifications, offering scalable manufacturing capabilities.

The company's BreathLogix "Workplace Series" device recently received National Highway Traffic Safety Association approval and was added to the U.S. Federal Register Conforming Products List for breath alcohol screen devices. Additionally, Cannabix secured an exclusive distribution agreement with Breathalyser Sales & Service Pty Ltd. for Australia, New Zealand, and Pacific Islands markets.

The company is also in discussions with U.S. and Canadian manufacturers regarding its Marijuana Breath Testing technology, including its Breath Collection Unit, Breath Cartridge technology, and disposable parts.

Cannabix Technologies (BLOZF) has secured its first international distribution agreement for its BreathLogix autonomous alcohol breathalyzer devices. The exclusive 2-year agreement with Breathalyser Sales & Service Pty Ltd. covers Australia, New Zealand, and the Pacific Islands. BreathLogix offers rapid breath alcohol testing with integrated photo capture, real-time manager alerts, and cloud reporting capabilities.

The device features patent-pending pre-calibrated sensor cartridge technology and can be integrated with various access control systems. Target markets include mining, oil and gas, industrial, trucking, and warehousing sectors. The company is also advancing its Marijuana Breath Test (MBT) technology and seeking distribution partners in the United States.

Cannabix Technologies (BLOZF) has received NHTSA approval for its BreathLogix Workplace Series alcohol breathalyzer. The device has met the USDOT model specifications for breath alcohol screening devices and will be added to the U.S. Federal Register Conforming Products List. The BreathLogix WS features rapid breath alcohol checking, simultaneous user photo capture, and real-time manager alerts.

Key features include precise BAC level detection, SMS/email test reports, integration capabilities with various access control systems, and patent-pending pre-calibrated sensor cartridge technology. The device is designed for multiple applications including construction, transportation, healthcare, manufacturing, and other safety-sensitive industries.

Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) has signed a non-exclusive distribution agreement with Alco Prevention Canada for North America to distribute its BreathLogix autonomous alcohol breathalyzer devices. Alco Prevention, based in Montreal, has 4,000 points of sale and 45 agents worldwide.

The BreathLogix device features patent-pending pre-calibrated cartridge technology, eliminating the need for costly calibration equipment and technician visits. The system autonomously performs alcohol screening, captures user photos for identity confirmation, and delivers real-time BAC results with automated reporting via text, email, and web portal.

The device is currently being used by the Friedel Clinic in Montana under the 24/7 Sobriety Program, demonstrating cost and time savings by eliminating the need for dedicated screening administrators. The company is in discussions with additional distributors in North America and other regions.

Cannabix Technologies (OTC: BLOZF) announces its participation in the Tennessee Safety and Health Conference (TSHC) in Nashville starting April 7th, 2025. The company will showcase two key technologies alongside AlcoPro Inc.: the Marijuana Breath Test (MBT) and BreathLogix alcohol screening device.

The MBT is a portable breath collection system for detecting recent THC use, validated by Omega Laboratories in March 2025. It can detect multiple cannabinoids including Δ-9-THC, Δ-8-THC, CBD, and CBN. Unlike traditional testing methods, it focuses on a more relevant consumption window.

The BreathLogix series features unmanned wall-mounted alcohol screening devices with patent-pending pre-calibrated cartridge technology. These devices offer autonomous sobriety checking, identity confirmation, and real-time BAC level reporting via text, email, and web portal.

Additionally, the company announced a change in auditor from Saturna Group to SHIM and Associates LLP, effective April 4th, 2025.